Arash Moradzadeh, MD
Otolaryngology/Facial Plastic Surgery · Beverly Hills, CANPI 1306930821
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 80.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $2,034 and has fallen 60.4% since, to $806 in 2025. Among otolaryngology/facial plastic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 215 payments — averaging $44.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Galderma Laboratories, L.p.$1K
- Merz North America, Inc.$279
- Stryker$183
- Smith+Nephew$109
- Aerin Medical Inc.$69
- plus $136 from 4 others
What the payments were for
- Consulting fees$1,00011%
- Speaking & faculty fees$4,44647%
- Food & beverage$4,02842%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 151 | $7,686 |
| Galderma Laboratories, L.p. | 33 | $1,033 |
| Merz North America, Inc. | 12 | $279 |
| Stryker | 6 | $183 |
| Smith+Nephew | 3 | $109 |
| Aerin Medical Inc. | 4 | $69 |
| Acelrx Pharmaceuticals, Inc. | 3 | $55 |
| Revance Therapeutics, Inc. | 1 | $39 |
| Vertical Pharmaceuticals, LLC | 1 | $22 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$264
How this compares
$9,495 in reported general payments places this provider in the 90th percentile of 102 otolaryngology/facial plastic surgery providers in California.
See all otolaryngology/facial plastic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 13 | $3,173 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 22 | $2,180 |
| Fluocinolone Acetonide Oil | 29 | $1,254 |
| Omeprazole | 32 | $350 |
| Azelastine Hcl | 15 | $328 |
| Esomeprazole Magnesium | 14 | $291 |
| Fluticasone Propionate | 37 | $267 |
| Ipratropium Bromide | 11 | $213 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $89 |
| Methylprednisolone | 12 | $70 |
| Famotidine | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Beverly Hills
- Paul NassifBeverly Hills$10K
- Babak AzizzadehBeverly Hills$10K
- David AlessiBeverly Hills$9K
- Karan DhirBeverly Hills$7K
- J SchnitmanBeverly Hills$7K
- Stephen FinkBeverly Hills$4K
- Payman SimoniBeverly Hills$3K
- David ShamouelianBeverly Hills$3K
- Sarmela SunderLancaster$85K
- Vasu DiviStanford$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.